Principal Securities’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$788	Buy	+59	New	+$788	﹤0.01%	3391
2024 Q2	–	Sell	-3	Closed	-$199	–	3446
2024 Q1	$199	Sell	3 -41	-93%	-$2.72K	﹤0.01%	3242
2023 Q4	$1.75K	Buy	+44	New	+$1.75K	﹤0.01%	2843